Science and art of protein formulation development
- PMID: 31306712
- DOI: 10.1016/j.ijpharm.2019.118505
Science and art of protein formulation development
Abstract
Protein pharmaceuticals have become a significant class of marketed drug products and are expected to grow steadily over the next decade. Development of a commercial protein product is, however, a rather complex process. A critical step in this process is formulation development, enabling the final product configuration. A number of challenges still exist in the formulation development process. This review is intended to discuss these challenges, to illustrate the basic formulation development processes, and to compare the options and strategies in practical formulation development.
Keywords: Aggregation; Formulation; Process; Protein; Stability; Storage.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Key considerations in formulation development for gene therapy products.Drug Discov Today. 2022 Jan;27(1):292-303. doi: 10.1016/j.drudis.2021.08.013. Epub 2021 Sep 6. Drug Discov Today. 2022. PMID: 34500102 Review.
-
Current perspectives on stability of protein drug products during formulation, fill and finish operations.Biotechnol Prog. 2008 May-Jun;24(3):504-14. doi: 10.1021/bp070462h. Epub 2008 May 17. Biotechnol Prog. 2008. PMID: 18484778 Review.
-
Fundamentals of freeze-drying.Pharm Biotechnol. 2002;14:281-360. doi: 10.1007/978-1-4615-0549-5_6. Pharm Biotechnol. 2002. PMID: 12189727 Review.
-
New Strategies for Improving the Development and Performance of Amorphous Solid Dispersions.AAPS PharmSciTech. 2018 Apr;19(3):978-990. doi: 10.1208/s12249-018-0953-z. Epub 2018 Jan 16. AAPS PharmSciTech. 2018. PMID: 29340977 Review.
-
Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.Expert Opin Drug Deliv. 2009 Nov;6(11):1219-30. doi: 10.1517/17425240903199143. Expert Opin Drug Deliv. 2009. PMID: 19678792 Review.
Cited by
-
Nano Differential Scanning Fluorimetry-Based Thermal Stability Screening and Optimal Buffer Selection for Immunoglobulin G.Pharmaceuticals (Basel). 2021 Dec 25;15(1):29. doi: 10.3390/ph15010029. Pharmaceuticals (Basel). 2021. PMID: 35056086 Free PMC article.
-
A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations.MAbs. 2023 Jan-Dec;15(1):2205540. doi: 10.1080/19420862.2023.2205540. MAbs. 2023. PMID: 37243580 Free PMC article.
-
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies.Pharm Res. 2025 Jan;42(1):151-171. doi: 10.1007/s11095-024-03801-3. Epub 2025 Jan 17. Pharm Res. 2025. PMID: 39824982
-
Excipient Innovation Through Precompetitive Research.Pharm Res. 2021 Dec;38(12):2179-2184. doi: 10.1007/s11095-021-03157-y. Epub 2021 Dec 20. Pharm Res. 2021. PMID: 34931284 Free PMC article. No abstract available.
-
Investigating the stabilisation of IFN-α2a by replica exchange molecular dynamics simulation.J Mol Model. 2022 Jul 26;28(8):232. doi: 10.1007/s00894-022-05212-w. J Mol Model. 2022. PMID: 35882698
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources